Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Study Identifier
190342-021
CT.gov Identifier
NCT00652483
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
    • Study Drug
  • Brimonidine ophthalmic solution 0.1%
  • Brimonidine ophthalmic solution 0.2%
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Ocular hypertension or glaucoma in both eyes
    Exclusion Criteria:
    * Uncontrolled systemic disease * Known allergy or sensitivity to brimonidine

    Protocol Summary

    This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic solution compared with brimonidine 0.2% ophthalmic solution in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Atlanta, Georgia, United States
    Status
    Not applicable